Phase II: Augmented Reality for Chemical and Biological Defense (ARCBaD)
Award amount
$597,487Program and phase
SBIR · Phase IIAward year
2023Award details
- Awarding agency
- Department of Defense
- Branch
- Office for Chemical and Biological Defense
- Recipient company
- AUGMNTR, INC.
- Proposal award date
- 2023-03-27
- Contract end date
- 2024-03-31
- UEI
- C1A7J62R7ME5
- Solicitation number
- 21.2
- Topic code
- CBD212-002
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Augmented Reality Surgical Visualization Tool for Combat Casualty Care
- Phase II Follow-on for the Medic's Enahnced Diagnostic Imaging Companion (MEDIC Phase II)
- Terrain Strength Estimation Using Remote Sensing for Route Planning and Real Time Autonomous Mobility
- ÃÂÃÂ Augmented Reality for Chemical and Biological Defense (ARCBaD)ÃÂÃÂ
- A Realizable Single Amphibious Integrated Precision Augmented Reality Navigation (SAIPAN) System
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- CBRNE Augmented Reality Display and Device Integration Network
- HoloWarriorTM Augmented Reality CBRN Threat Display for Mounted Situational Awareness
- Augmented reality and data fusion for CBRN threats
- CBRNE Augmented Reality Display and Device Integration Network
Research funding history
10 SBIR/STTR records share this UEI (2018–2023). Reported award amounts total $5,163,314. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense